Brighten Optix Corporation (6747.TWO)

183.00 +1.00 (+0.55%) At close: 01:30PM CST

Brighten Optix Corporation

No.150, Chengde Road
6th Floor-1 Section 4 Shilin District
Taipei 11167
Taiwan
886 2 2880 1778
https://www.brightenoptix.com.tw

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Description

Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers hard contact lenses under HiClear and Soclear brands; soft contact lenses under Brio+moist, iDealsoft, and MyOKvision names; contact lens care potion under the Oxy vision plus Briomoist and Mu likang brands; and other ancillary products, as well as night-wear orthokeratology hard contact lenses. Brighten Optix Corporation is based in Taipei, Taiwan.

Corporate governance

Brighten Optix Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.